| Name | Title | Contact Details |
|---|---|---|
Mark McClanahan |
Chief Financial Officer (CFO) | Profile |
Eric Robertson |
Sr. Director, RandD QA | Profile |
Karen Weisbach |
Vice President People Culture | Profile |
ClearTrial, LLC is a Westmont, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
NY CREATES is a world leading R&D, innovation hub and commercialization facilitator that works with researchers in industry, academia and national labs to leverage the state of the art infrastructure in upstate New York and to partner with NY CREATES’ ...
Sirius Medicine is a Loveland, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Meridian Health Services provides a safe, medically-supervised environment that respects your privacy and supports your physical and emotional health.
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.